Senior insider sale
CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$232.1K
6K shares
What this filing means
VIVALDI COELHO ROGERIO plans to sell 6K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $232.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001950047-26-006823
Director
Since Jan 2022
6K
Shares to sell
$232.1K
Approx. market value
6K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/7/2024
6KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/7/2024 | Restricted Stock Units N/A | 6K | — |
| Total | 6K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6K
Market value
$232.1K
7/2/2026
Total
Units
6K
Value
$232.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2026 | 6K | $232.1K | NASDAQ | Planned |
| Total | 6K | $232.1K | ||